Carcinosarcoma

14 clinical trials · Condition

Record	Firm	Date
(VELA) Study of BLU-222 in Advanced Solid Tumors (NCT05252416)	Blueprint Medicines Corporation	2022-04-07
Camrelizumab Combined With Apatinib in the Treatment of Advanced Sarcomatoid Carcinoma or Carcinosarcoma (NCT05265793)	Fudan University	2021-11-21
Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus. (NCT04458597)	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	2020-08-26
Pamiparib in Fusion Positive, Reversion Negative High Grade Serous Ovarian Cancer or Carcinosarcoma With BRCA1/2 Gene Mutations If Progression on Substrate Poly ADP Ribose Polymerase Inhibitbor (PARPI) or Chemotherapy (NCT03933761)	Australia New Zealand Gynaecological Oncology Group	2019-07-29
Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage (NCT04688749)	Aristotle University Of Thessaloniki	2019-07-17
GISAR German Interdisciplinary Sarcoma Registry (NCT04122872)	Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest	2018-11-29
Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel? (NCT03570437)	University of Manchester	2018-05-17
A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma (NCT03395080)	Leap Therapeutics, Inc.	2018-03-05
A Study of Nivolumab in Selected Uterine Cancer Patients (NCT03241745)	Memorial Sloan Kettering Cancer Center	2017-08-03
Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors (NCT00815945)	AGO Study Group	2008-06-01
Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors (NCT04681248)	Leap Therapeutics, Inc.

Track Carcinosarcoma automatically

Every clearance here is in the API, with alerts when new ones post.